文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

日本国家登记数据显示:疫情期间接受机械通气伴或不伴ECMO的重症COVID-19患者生存趋势

Trends in survival during the pandemic in patients with critical COVID-19 receiving mechanical ventilation with or without ECMO: analysis of the Japanese national registry data.
PubMed 文献 · Crit Care · 2022-11-15
一句话结论日本全国登记数据显示,五次疫情中机械通气患者生存率从76%升至84%,ECMO患者稳定在60-68%;年龄≥59岁、ECMO前通气≥3天、机构ECMO经验≥11例为ECMO患者独立预后因素。

该研究基于日本覆盖>80% ICU的前瞻性全国登记数据,纳入2020年2月至2021年11月接受机械通气的重症COVID-19肺炎患者,评估五次疫情中生存率变化及预后因素。共9418例接受机械通气,其中1214例(13%)接受ECMO;机械通气患者总生存率79%,ECMO患者65%。机械通气患者生存率从第一次疫情的76%升至第五次疫情的84%(p<0.001),ECMO患者生存率在五次疫情中维持在60-68%(p=0.084)。年龄≥59岁(HR 2.17;95%CI 1.76-2.68)、启动ECMO前通气天数≥3天(HR 1.91;95%CI 1.57-2.32)和机构ECMO经验≥11例(HR 0.70;95%CI 0.58-0.85)是ECMO患者的独立预后因素。

要点

  • 日本全国登记中9418例接受机械通气的重症COVID-19患者,1214例(13%)接受ECMO,机械通气患者总生存率79%,ECMO患者65%。
  • 五次疫情中机械通气患者生存率从第一次疫情的76%升至第五次疫情的84%(p<0.001),ECMO患者生存率维持在60-68%(p=0.084)。
  • ECMO患者独立预后因素:年龄≥59岁(HR 2.17;95%CI 1.76-2.68)、启动ECMO前通气天数≥3天(HR 1.91;95%CI 1.57-2.32)、机构ECMO经验≥11例(HR 0.70;95%CI 0.58-0.85)。
  • ECMO患者生存率在五次疫情中未下降,年龄较大、ECMO前通气时间较长和机构ECMO经验较少可能是独立预后因素。

适用人群与场景

  • 日本ICU收治的重症COVID-19肺炎患者,接受机械通气和/或ECMO,纳入时间为2020年2月至2021年11月。

研究设计与关键结果

  • 研究类型为前瞻性观察性队列研究,基于覆盖日本>80% ICU的全国登记数据库,纳入9418例接受机械通气的患者,其中1214例(13%)接受ECMO。
  • 机械通气患者总生存率为79%,ECMO患者总生存率为65%。
  • 机械通气患者生存率从第一次疫情的76%升至第五次疫情的84%(p<0.001);ECMO患者生存率在第一次至第五次疫情中维持在60-68%(p=0.084)。
  • ECMO患者独立预后因素:年龄≥59岁(HR 2.17;95%CI 1.76-2.68)、启动ECMO前通气天数≥3天(HR 1.91;95%CI 1.57-2.32)、机构ECMO经验≥11例(HR 0.70;95%CI 0.58-0.85)。

证据类型、等级与局限

  • 证据类型:前瞻性观察性队列研究(基于日本全国登记数据库)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,年龄≥59岁、启动ECMO前通气天数≥3天和机构ECMO经验≥11例可能是接受ECMO的重症COVID-19患者的独立预后因素。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The survival rate of patients with critical coronavirus disease-19 (COVID-19) over time is inconsistent in different settings. In Japan, a national database was organized to monitor and share the patient generation across the country in an immediate response to the COVID-19 pandemic. This study aimed to evaluate changes in survival over time and the prognostic factors in critical COVID-19 patients receiving mechanical ventilation with/without extracorporeal membrane oxygenation (ECMO) using the largest database in Japan.

METHODS: This is a prospective observational cohort study of patients admitted to intensive care units in Japan with fatal COVID-19 pneumonia receiving mechanical ventilation and/or ECMO. We developed a prospective nationwide registry covering > 80% of intensive care units in Japan, and analyzed the association between patients' backgrounds, institutional ECMO experience, and timing of treatment initiation and prognosis between February 2020 and November 2021. Prognostic factors were evaluated by Kaplan-Meier analysis and Cox proportional hazards analysis.

RESULTS: A total of 9418 patients were ventilated, of whom 1214 (13%) received ECMO. The overall survival rate for ventilated patients was 79%, 65% for those receiving ECMO. There have been five outbreaks in Japan to date. The survival rate of ventilated patients increased from 76% in the first outbreak to 84% in the fifth outbreak (p < 0.001). The survival rate of ECMO patients remained unchanged at 60-68% from the first to fifth outbreaks (p = 0.084). Age of ≥ 59 (hazard ratio [HR] 2.17; 95% confidence interval [CI] 1.76-2.68), ventilator days of ≥ 3 before starting ECMO (HR 1.91; 95% CI 1.57-2.32), and institutional ECMO experiences of ≥ 11 (HR 0.70; 95% CI 0.58-0.85) were independent prognostic factors for ECMO.

CONCLUSIONS: During five COVID-19 outbreaks in Japan, the survival rate of ventilated patients tended to have gradually improved, and that of ECMO patients did not deteriorate. Older age, longer ventilator days before starting ECMO, and fewer institutional ECMO experiences may be independent prognostic factors for critical COVID-19 patients receiving ECMO.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Ohshimo S, Liu K, Ogura T, et al. Trends in survival during the pandemic in patients with critical COVID-19 receiving mechanical ventilation with or without ECMO: analysis of the Japanese national registry data. Crit Care. 2022. PMID: 36380377. doi:10.1186/s13054-022-04187-7

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。